Research Article
“Yiqi Huayu, Wenyang Lishui” Prescription (YHWLP) Improves the Symptoms of Chronic Obstructive Pulmonary Disease-Induced Chronic Pulmonary Heart Disease by Inhibiting the RhoA/ROCK Signaling Pathway
Table 4
Comparison of decreases in PT, aPTT, Fbg, and D-dimer (relative to baseline) between the two groups.
| ||||||||||||||||||||||||||||||
Notes: PT, prothrombin time; aPTT, activated partial thromboplastin time; Fbg, fibrinogen; D-D, D-dimer. Values are mean ± standard deviation. , . |